- REZUROCK is approved by the U.S. FDA for the treatment of adult and pediatric patients 12 years and older...
Nature Medicine publication shows that neutralizing antibodies are critical to prevent or reduce the severity of a COVID-19 infection, including...
SOUTH SAN FRANCISCO, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Fountain Therapeutics, a biopharmaceutical company building a pipeline of therapeutics...
Company to introduce design of upcoming Phase 2 study of XPro1595 in Alzheimer’s disease, which is expected to commence this...
Results from the study provide evidence of standardization of an automated spatial biology workflow, based on the company’s Phenoptics™ multiplex...
New patent bolsters intellectual property protection for Firdapse®First in a family of four pending patents for Firdapse® to issueCORAL GABLES,...
– First approval in the world of Bylvay for the treatment of PFIC – – Only once-daily drug indicated to...
—Funding to Enhance Research and Development of Pipeline, Including Lead Program Targeting Activated KRASG12C— —Proceeds to Further...
Deal strengthens BioNTech’s cell therapy pipeline by accelerating individualized solid tumor Neoantigen TCR cell therapy research and development program and...
OVATION 2 Study is 50% Enrolled; Excellent R0 Surgical Resection Noted Novel Gene-Mediated Immunotherapy is Safe and Demonstrates an Acceptable...
ROCKAWAY, NJ, July 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”), (NASDAQ: ECOR), a commercial-stage bioelectronic medicine company, today...
DELRAY BEACH, Fla., July 19, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) will announce its financial results for...
SANTA BARBARA, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics...
InnerScope (INND) partners with New to The Street TV for production and broadcasting of commercials and digital billboards as part...
-First precision approach to IBD by utilizing a companion diagnostic to identify patients- -Phase 2a initiation in Crohn’s Disease on...
BRIDGEWATER, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced the...
BOSTON, July 19, 2021 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing...
Acquisition Advances Transformation Into Platform Company Focused on Cell, Gene Editing and Cytokine Therapy Company to hold Conference Call Today,...
VANCOUVER, British Columbia, July 19, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), an emerging...
A global platform to market the Company’s portfolio across 40 countriesMELBOURNE, Australia, July 19, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies...